The Face of Molecular Diagnostics

Adam Joelsson, bioMérieux


bioMérieux’s Senior Director of Technology/R&D, Adam Joellson, brings more than 15 years of expertise in molecular assay development from the Philadelphia-based Predictive Diagnostics Innovation Center.

There, Joelsson leads a team of innovators as part of the xPROTM Program. The program advances molecular diagnostics through the rapid development of innovative custom testing solutions to ensure public health. These cutting-edge diagnostic platforms and applications serve any-size food, beverage, dietary supplement, or cannabis company who is looking to improve their quality assurance and diagnostic testing services in as little as 90 days.

bioMérieux won the 2022 Food Safety Innovation Award for Predictive Diagnostics from the International Association for Food Protection — the xPRO Program is one of the pillars of Predictive Diagnostics.

“Science is one of the most creative industries — what is innovation if not problem solving?” said Joelsson. “xPRO is rooted in creativity. Our team is committed to developing versatile solutions that simultaneously solve very specific client problems that can also be adopted at scale to segments at large.”

May June 2023
Explore the May June 2023 Issue

Check out more from this issue and find your next story to read.